SoniVie receives IDE approval from FDA for its Pilot study to treat Hypertension with its Renal Artery Denervation TIVUS™ technology

TEL AVIV, Israel, June 20, 2022 /PRNewswire/ — SoniVie, an Israeli company developing a novel proprietary Therapeutic Intra-Vascular Ultrasound System (TIVUS™) to treat a variety of hypertensive disorders, announced that on May 5th 2022 the U.S. Food and Drug Administration granted…

New app from Health in Transportation & NuraLogix allows drivers to perform CDL health checks that target hypertension and type-2 diabetes.

DETROIT, June 8, 2022 /PRNewswire/ — Professional drivers, working both in mass transit and in trucking, are now able to access a 30-second CDL health check that focuses on the dangers of hypertension and type-2 diabetes by utilizing a new…

Merck Foundation Marks World Hypertension Day 2022 in Partnership With African First Ladies by Building Cardiovascular, Diabetes, and Endocrinology Care Capacity in Africa

Business Wire India Merck Foundation, the philanthropic arm of Merck KGaA Germany marks World Hypertension Day 2022 in partnership with African First Ladies, Ministries of Health, Medical Societies and Academia, through their long-term commitment toward building Cardiovascular, Diabetes, and Endocrinology…

Merck Foundation and African First Ladies mark World Hypertension Day 2021 by Building Cardiovascular, Diabetes, and Endocrinology Care Capacity in Africa, Asia and Latin America

Business Wire India Merck Foundation in partnership with African First Ladies and Ministries of Health continues to provide their scholarship of one-year Post-Graduate Diploma and two-year Master degree in both Preventive Cardiovascular Medicine, Endocrinology and Diabetes for 628 doctors from…

Merck Foundation marks Merck Foundation and African First Ladies Mark World Hypertension Day 2021 by Building Cardiovascular, Diabetes, and Endocrinology Care Capacity in Africa, Asia and Latin America

Business Wire India Merck Foundation in partnership with African First Ladies and Ministries of Health continues to provide their scholarship of one-year Post-Graduate Diploma and two-year Master degree in both Preventive Cardiovascular Medicine, Endocrinology and Diabetes for 628 doctors from…

ReCor Medical Announces Results from Landmark RADIANCE-HTN TRIO Study, Showing Clinically Significant Blood Pressure Reduction with the Paradise Ultrasound RDN System in Patients with Resistant Hypertension

PALO ALTO, Calif., May 16, 2021 /PRNewswire/ — ReCor Medical, Inc. (“ReCor”), a wholly-owned subsidiary of Otsuka Medical Devices Co., Ltd., today presented the primary endpoint data from the randomized sham-controlled RADIANCE-HTN TRIO (“TRIO”) study.  In subjects with resistant hypertension, those treated…

Merck Foundation crusades against hypertension

Merck Foundation marks World Hypertension Day 2019 Merck Foundation, the philanthropic arm of Merck KGaA Germany marked ‘World Hypertension Day 2019’ by building hypertension care capacity in Africa and Asia through their nationwide programs. “Merck Foundation launched ‘Merck Hypertension Award’…

HIGHLIGHTS FROM THE ALZHEIMER’S ASSOCIATION INTERNATIONAL CONFERENCE 2022

SAN DIEGO, Aug. 3, 2022 /PRNewswire/ — New research reported at the Alzheimer’s Association International Conference® (AAIC®) 2022 covered the breadth of Alzheimer’s and dementia research, including the basic biology of aging and the brain, risk factors and prevention strategies, and…

HISTORY OF HYPERTENSIVE DISORDERS DURING PREGNANCY LINKED TO INCREASED RISK OF DEMENTIA

SAN DIEGO, Aug. 3, 2022 /PRNewswire/ –Experiences of high blood pressure disorders during pregnancy are associated with an increased risk of vascular dementia and accelerated brain aging, according to studies reported today at the Alzheimer’s Association International Conference® (AAIC®) 2022…

Nicox to Participate in Financial and Scientific Events in Q3 2022

Press Release Nicox to Participate in Financial and Scientific Events in Q3 2022 August 3, 2022 – release at 7:30 am CET Sophia Antipolis, France Nicox SA (Euronext Paris: FR0013018124, COX), an international ophthalmology company, announced that members of the…